Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Margherita, Mirabile"'
Autor:
Elena Genovese, Margherita Mirabile, Sebastiano Rontauroli, Stefano Sartini, Sebastian Fantini, Lara Tavernari, Monica Maccaferri, Paola Guglielmelli, Elisa Bianchi, Sandra Parenti, Chiara Carretta, Selene Mallia, Sara Castellano, Corrado Colasante, Manjola Balliu, Niccolò Bartalucci, Raffaele Palmieri, Tiziana Ottone, Barbara Mora, Leonardo Potenza, Francesco Passamonti, Maria Teresa Voso, Mario Luppi, Alessandro Maria Vannucchi, Enrico Tagliafico, Rossella Manfredini, on behalf of the Mynerva (MYeloid NEoplasms Research Venture AIRC)
Publikováno v:
Antioxidants, Vol 11, Iss 1, p 113 (2022)
Myelofibrosis (MF) is the Philadelphia-negative myeloproliferative neoplasm characterized by the worst prognosis and no response to conventional therapy. Driver mutations in JAK2 and CALR impact on JAK-STAT pathway activation but also on the producti
Externí odkaz:
https://doaj.org/article/753fc1e1ade94842b36e1ec1512b21f5
Autor:
Elisa Bianchi, Sebastiano Rontauroli, Lara Tavernari, Margherita Mirabile, Francesca Pedrazzi, Elena Genovese, Stefano Sartini, Massimiliano Dall’Ora, Giulia Grisendi, Luca Fabbiani, Monica Maccaferri, Chiara Carretta, Sandra Parenti, Sebastian Fantini, Niccolò Bartalucci, Laura Calabresi, Manjola Balliu, Paola Guglielmelli, Leonardo Potenza, Enrico Tagliafico, Lorena Losi, Massimo Dominici, Mario Luppi, Alessandro Maria Vannucchi, Rossella Manfredini
Clonal myeloproliferation and development of bone marrow (BM) fibrosis are the major pathogenetic events in myelofibrosis (MF). The identification of novel antifibrotic strategies is of utmost importance since the effectiveness of current therapies i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adccd02091cf2ea6826e20a40f45ac86
https://hdl.handle.net/11380/1305528
https://hdl.handle.net/11380/1305528
Autor:
Lara Tavernari, Sebastiano Rontauroli, Monica Maccaferri, Barbara Mora, Elia Venturelli, Elisa Bianchi, Sandra Parenti, Elena Genovese, Paola Guglielmelli, Chiara Carretta, Margherita Mirabile, Stefano Sartini, Corrado Colasante, Leonardo Potenza, Francesco Passamonti, Enrico Tagliafico, Mario Luppi, Alessandro M. Vannucchi, Rossella Manfredini
Publikováno v:
Blood. 140:9600-9601
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33b369a905161118aeb910751402f81d
https://doi.org/10.1182/blood-2022-167161
https://doi.org/10.1182/blood-2022-167161
Autor:
Sebastian, Fantini, Sebastiano, Rontauroli, Stefano, Sartini, Margherita, Mirabile, Elisa, Bianchi, Filippo, Badii, Monica, Maccaferri, Paola, Guglielmelli, Tiziana, Ottone, Raffaele, Palmieri, Elena, Genovese, Chiara, Carretta, Sandra, Parenti, Selene, Mallia, Lara, Tavernari, Costanza, Salvadori, Francesca, Gesullo, Chiara, Maccari, Michela, Zizza, Alexis, Grande, Silvia, Salmoiraghi, Barbara, Mora, Leonardo, Potenza, Vittorio, Rosti, Francesco, Passamonti, Alessandro, Rambaldi, Maria Teresa, Voso, Cristina, Mecucci, Enrico, Tagliafico, Mario, Luppi, Alessandro Maria, Vannucchi, Rossella, Manfredini
Publikováno v:
Cancers
Simple Summary Myelofibrosis (MF) displays the worst prognosis among Philadelphia-negative chronic myeloproliferative neoplasms. There is no curative therapy for MF, except for bone marrow transplantation, which however has a consistent percentage of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8fa17fb22346af6c64f5423974b70af1
https://pubmed.ncbi.nlm.nih.gov/34638230
https://pubmed.ncbi.nlm.nih.gov/34638230